Indications

  • Neurological Rehabilitation of C and D phases in patients with e.g. hypoxic brain damage, ischemic stroke, intracerebral hemorrhage, subarachnoid hemorrhage, craniocerebral injury, critical neuro- and myopathies and Guillain-Barré-Strohl syndrome, cerebral vasculitis, state following cerebral venous and sinus thrombosis.
  • Status following meningitis and encephalitis
  • Parkinson's disease and other movement disorders (dystonia, Huntington's chorea, ataxia)
  • Patients with a dysphagia that requires supervision, a tracheostomy needing aspiration or behavioral and orientation disorder that requires supervision
  • Status following surgeries of space-occupying processes in the spinal cord or the brain
  • Neurotraumatological sequelae (state following craniocerebral injury II III.0, state following spinal injury)
  • Neurodegenerative diseases (incipient dementia, motor neuron diseases)
  • Polyneuropathy
  • Muscle diseases
  • Functional neurological disorders
  • Patients with negative Barthel Index
  • Care for patients with PEG
  • State following surgery of intracranial vessels and vessels leading to the brain
  • Encephalomyelitis disseminata (multiple sclerosis)
  • Intensive medical rehabilitation with weaning off oxygen (weaning)
  • Patients with artificial hearts with neurological symptoms